MARKET WIREYahoo Finance • 6h ago
BGM Strengthens the Firm's Northeast PresenceYahoo Finance report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
Why BGM Stock Traded Steady Today — RQD Quant Desk Flash
$9.54 0.00% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)
EXT / AFTER-HRS: $9.52
BGM Group Ltd. (Class A) (BGM) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
ROARABLE D- • RED ALERT
Cap $127.4M
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER
Click Any Pre-Computed AI Quant Specialist Briefing on BGM Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief)
Is BGM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼
As of 2026-11-02, BGM Group Ltd. (Class A) (NASDAQ: BGM) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $9.54 (0.00% 1D, market cap $127.4M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BGM ranks #683 in composite RQD confidence.
✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief)
How does BGM compare to FHTX and HURA in the Health Care sector?
▼
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), BGM carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 16.6%, and ROIC of —. By comparison, FHTX (Foghorn Therapeutics Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $124.1M) and HURA (TuHURA Biosciences Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $131.3M). Among the 5-stock peer group, BGM leads on earnings multiple (N/A) while FHTX leads on capital efficiency (-35.0% ROIC).
✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief)
What are the biggest fundamental strengths and SEC risk factors for BGM?
▼
Per BGM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001779578), BGM Group Ltd. (Class A) generated $37.9M in revenue (+51.1% YoY), -$19.9M in net income, and -$3.9M in free cash flow against $433.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
EXT / AFTER-HRS: $9.52 (-0.19%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →RQD QUANT TACHOMETERRED ALERT • D-
2-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
5-PILLAR SNOWFLAKE RADARRw D- · Rk D-
Each axis scored 0–20
12M PRICE TARGET CONE-10.4% Base Target
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for BGM)Realized 20D OHLCV Swing Band: ±12.5%
Deterministic 5-Pillar Attribution (35/100 Composite)
🔍 WHY BGM SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: Cash Engine Quality+12/20 pts (34% of score)
SEC XBRL FY 2025 (10-K): 0% FCF Margin ($0 FCF) & 16.6% Gross Margin
▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (23% of score)
Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 2/9
▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)Grade D$10.75-19.5% Next Q
43
Q2 (-2Q)Grade D$8.65-9.2% Next Q
40
Q3 (-1Q)Grade E$7.85+21.5% Next Q
38
CurrentGrade D-$9.54-8.5% Hist 90D α
35
Trajectory: D (43) → D- (35)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER
⚔️ Adversarial Opposing Case: What Could Spark a BGM Turnaround Squeeze
While BGM currently carries a cautious 35/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
🚀 Contrarian Squeeze Trigger #1
Established market leader in Health Care with deep daily trading liquidity.
🚀 Contrarian Squeeze Trigger #2
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($8.51) and Max Pain ($10.02) forces dealer call-delta covering toward $317.52.
🚀 Contrarian Squeeze Trigger #3
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
🎲 LIVE PREDICTION MARKET ODDS TIED TO $BGM• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “BGM Beats Next Quarter EPS Consensus (Dec 29, 2026) & Holds Above 200D SMA”
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why BGM Stock Traded Steady Today — RQD Quant Desk Flash
BGM Group Ltd. (Class A) (BGM) slipped 0.00% to $9.54, trading at 2% of its 52-week range ($6.45 – $302.4). Stretched risk/reward at current multiples (17% profit margin) under elevated 10-year interest-rate pressure.
- ▸Technical Tape: Trading at 2% of its 52-week range ($6.45 – $302.4) with RSI-14 at 56.6 (BULLISH MOMENTUM).
- ▸Volatility Profile: Historical 20-day realized swing band of ±12.5% around $9.54 (no active unusual options sweep snapshot on file).
- ▸Fundamental Anchor: Roarable D- (Sell) backed by 16.6% gross margin and $0 annual free cash flow.
Live BGM Headlines & Catalysts
RISK WATCHkalkine.ca • 9h ago
Why Is BGM Group (NASDAQ:BGM) Stock Down 8% Today, and What Are Investors Missing After a Run of Trading Halts?kalkine.ca report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
MARKET WIREStock Traders Daily • 12h ago
Responsive Playbooks and the BGM InflectionStock Traders Daily report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
MARKET WIRENFHS Network • 15h ago
Team Highlights: Varsity Football BGM Community High School vs. Martensdale-St Marys Jr/Sr High School - BGMNFHS Network report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
MARKET WIREMarketBeat • 18h ago
Promising Chinese Stocks To Watch Today - October 5thMarketBeat report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
MARKET WIRETradingKey • 21h ago
Top U.S. Stock Losers: Biggest Price DeclinesTradingKey report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
RISK WATCHCinema Express • 1d ago
Jailer 2: Hrithik Roshan acknowledges cameo in Rajinikanth starrer, drops his character BGMCinema Express report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
MARKET WIREkalkine.ca • 1d ago
Qilian International Holding Group Limited (NASDAQ: BGM) Stock Price, News & Analysiskalkine.ca report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk
Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring BGM)
- ✓Walkthrough of BGM's RQD Radar, SEC cash-conversion gap & downside invalidation levels
- ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
- ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
BGM // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +8.53%▼ DESCENDING CHANNEL
2026-10-30O $9.54H $9.54L $9.54C $9.54
RES: $10.31SUP: $6.12SMA50: $8.51SMA200: $19.20
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
BGM Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.0%/yr Implied 5Y Growth
vs. +51.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on BGM today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for BGM. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for BGM today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK
📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (BGM)
Health Care Rank #683 of 1016
⚔️ FHTX vs BGM Full Matrix →
1. Head-to-Head Health Care Peer Comparison (BGM vs. FHTX, HURA, CATX, SPRB)
Industry: Biotechnology: Pharmaceutical Preparations (489 Tracked Issuers)Across 1016 tracked Health Care securities in the Roarable RQD universe, BGM Group Ltd. (Class A) (BGM) ranks #683 by composite RQD confidence (35/100, grade D-) and #629 by equity capitalization ($127.4M). Within this direct 5-issuer industry benchmark cohort, BGM leads on earnings valuation at N/A trailing P/E, while FHTX leads on capital efficiency and profitability with -35.0% ROIC and — gross margin. SPRB currently holds the highest overall quantitative score in the immediate peer group at 42/100 (D-) compared with BGM at 35/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| BGM
ACTIVE
BGM Group Ltd. (Class A) | D- | 35/100 | — | 16.6% | — | 0.00% | $127.4M | Benchmark Subject |
| FHTX Foghorn Therapeutics Inc. | E | 32/100 | — | — | -35.0% | -0.48% | $124.1M | /fhtx-vs-bgm → |
| HURA TuHURA Biosciences Inc. | D- | 40/100 | — | — | -35.0% | -6.31% | $131.3M | /hura-vs-bgm → |
| CATX Perspective Therapeutics Inc. | D- | 37/100 | — | — | -35.0% | -1.71% | $133.6M | /catx-vs-bgm → |
| SPRB Spruce Biosciences Inc. | D- | 42/100 | — | — | -35.0% | -0.92% | $134.6M | /sprb-vs-bgm → |
2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)
SEC EDGAR 10-K • FILED 2025-09-30 • CIK 0001779578In its most recent audited fiscal period (FY2025, filed 2025-09-30), BGM Group Ltd. (Class A) (BGM) reported GAAP revenue of $37.9M (+51.1% vs. FY2024 revenue of $25.1M , and -18.4% cumulative change since FY2023) , GAAP net income of -$19.9M, operating cash flow of -$2.4M, and free cash flow of -$3.9M (-1395.3% YoY). On the balance sheet, BGM closed FY2025 with $433.8M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2025-09-30 | $37.9M | -$19.9M | -$2.4M | -$3.9M | $433.8M | — |
| FY2024 (FY) | 2024-09-30 | $25.1M | -$1.4M | $544.2K | $304.1K | — | — |
| FY2023 (FY) | 2023-09-30 | $46.5M | -$7.8M | $312.2K | $312.2K | — | — |
3. BGM Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)
✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLEDIs BGM stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
As of 2026-11-02, BGM Group Ltd. (Class A) (NASDAQ: BGM) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $9.54 (0.00% 1D, market cap $127.4M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 6/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 6/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, BGM ranks #683 in composite RQD confidence.
How does BGM compare to FHTX and HURA in the Health Care sector?
Within the Health Care sector (Biotechnology: Pharmaceutical Preparations), BGM carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 16.6%, and ROIC of —. By comparison, FHTX (Foghorn Therapeutics Inc.) holds a E grade (32/100 RQD, P/E N/A, ROIC -35.0%, cap $124.1M) and HURA (TuHURA Biosciences Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $131.3M). Among the 5-stock peer group, BGM leads on earnings multiple (N/A) while FHTX leads on capital efficiency (-35.0% ROIC).
What are the biggest fundamental strengths and SEC risk factors for BGM?
Per BGM's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-09-30, CIK 0001779578), BGM Group Ltd. (Class A) generated $37.9M in revenue (+51.1% YoY), -$19.9M in net income, and -$3.9M in free cash flow against $433.8M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Where is BGM trading relative to its 50-day, 200-day, and 52-week technical levels?
BGM last traded at $9.54 (0.00% on volume of 299 shares), positioning the stock +12.10% above its 50-day simple moving average ($8.51) and -50.31% below its 200-day simple moving average ($19.20). Across its 52-week range of $6.45 to $302.40, BGM sits at the 1.0% percentile with a 14-day RSI of 56.6 (BULLISH MOMENTUM) and an implied next-earnings move of ±12.5% ($8.35 to $10.73).
BGM Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is BGM stock moving today?
Why BGM Stock Traded Steady Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (17% profit margin) under elevated 10-year interest-rate pressure.
ROARABLE RATING BRIEF • RQD 35/100 (D-)
✓ STAGE-C NUMBER FIREWALL VERIFIED
BGM — BGM Group Ltd. (Class A): What the Facts Mean to a Prospective Investor
Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:43:11Z
Roarable Rating Brief: What This Means to a Prospective Investor
Per the Roarable RQD rating, BGM scores 35 out of 100, graded D-, with the verdict "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are: Fundamental Cash Engine at 12 of 20 (ROIC 0%; FCF yield -3.09%); Whale 13F Flow at 6 of 20 (institutional accumulation and options positioning); Insider Conviction at 3 of 20 (SEC Form 4 and Congressional PTR cluster flow); Macro Regime Fit at 6 of 20 (Beta 1.0; sector sensitivity); and Forensic Balance Sheet at 8 of 20 (Altman Z 2.5; Piotroski F 2/9; Debt/Equity 0.5). For a prospective investor, the weakest pillars are insider conviction and flow, while the cash engine is negative on free cash flow yield and zero on ROIC. The forensic balance sheet is the strongest of the weak pillars, with a leverage figure of 0.5 Debt/Equity, but the Piotroski score of 2 of 9 signals limited financial-quality strength. Any upside case would depend on a turnaround in operating economics that the source data does not yet show.
Business
BGM Group Ltd. (Class A) is a NASDAQ-listed issuer in the Health Care sector, within the Biotechnology: Pharmaceutical Preparations industry, per the company profile. The source data does not describe its specific products, customers, or revenue model. Per the SEC financials, the company reported revenue of $37.9M for FY 2025, indicating an operating business with meaningful top-line activity. Operating and net margins are negative, per the market data.
Financial Trend
| Period | Revenue | Operating Income | Net Income | EPS | FCF | Cash | Debt |
|---|---|---|---|---|---|---|---|
| FY 2025 | $37.9M | $-12.6M | $-19.9M | N/A | $-3.9M | N/A | N/A |
| FY 2024 | $25.1M | $-0.6M | $-1.4M | N/A | $0.3M | N/A | N/A |
| FY 2023 | $46.5M | $-2.6M | $-7.8M | N/A | $0.3M | N/A | N/A |
Per the market data, gross margin is 16.6%, operating margin -33.2%, and net margin -52.6%. ROIC is 0%. Per the Roarable RQD rating, the Altman Z-Score is 2.5, the Piotroski F-Score is 2 of 9, and Debt/Equity is 0.5. FY 2025 revenue rose from FY 2024 but losses widened sharply, with net income moving to $-19.9M. Cash and debt balances are not available in source data.
Recent Catalysts & News Wire Analysis
Per the recent news feed, six items reference BGM. The "BGM Strengthens the Firm's Northeast Presence" item, from Yahoo Finance, is marked YELLOW as a market wire item. A kalkine.ca report titled "Why Is BGM Group (NASDAQ:BGM) Stock Down 8% Today, and What Are Investors Missing After a Run of Trading Halts?" is marked RED under risk watch. A Stock Traders Daily item, "Responsive Playbooks and the BGM Inflection," is marked YELLOW. An NFHS Network item about a high school football game is unrelated to the company's business and carries no investment signal. A MarketBeat item, "Promising Chinese Stocks To Watch Today - October 5th," is marked YELLOW. A TradingKey item, "Top U.S. Stock Losers: Biggest Price Declines," is marked YELLOW. The Butterfly Supply-Chain Graph reports no supply chain and no proprietary signals.
Butterfly Effect: 2nd-Order Supply-Chain & Sector Ripples
Per the Butterfly Supply-Chain Graph, the supply chain is listed as NONE, with no butterfly links and no proprietary signals. Upstream and downstream dependencies, sector correlations, and second-order bottlenecks are therefore not available in source data. The sector is Health Care and the industry is Biotechnology: Pharmaceutical Preparations, but no linkage to specific suppliers, customers, or peers is provided.
Open Questions
- What products or therapies does BGM commercialize, and what drives its FY 2025 revenue of $37.9M?
- What are cash and debt balances, and how much runway exists given FCF of $-3.9M in FY 2025?
- What caused the reported operating loss to widen from $-0.6M in FY 2024 to $-12.6M in FY 2025?
- What do the risk-watch headlines about trading halts refer to, and were they material to the 8% decline described?
- What are the EPS, forward valuation, and any analyst or ownership data points that are currently missing?
BGM Live News Feed, Press Releases & Catalyst Wire
Real-time company headlines, analyst actions, and sector developments for BGM Group Ltd. (Class A) (BGM) • Click "Debate This Headline" to argue it in the Roar Pit below
🟡 MARKET WIRE Yahoo Finance • 6h ago
BGM Strengthens the Firm's Northeast Presence Yahoo Finance report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH kalkine.ca • 9h ago
Why Is BGM Group (NASDAQ:BGM) Stock Down 8% Today, and What Are Investors Missing After a Run of Trading Halts? kalkine.ca report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE Stock Traders Daily • 12h ago
Responsive Playbooks and the BGM Inflection Stock Traders Daily report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE NFHS Network • 15h ago
Team Highlights: Varsity Football BGM Community High School vs. Martensdale-St Marys Jr/Sr High School - BGM NFHS Network report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE MarketBeat • 18h ago
Promising Chinese Stocks To Watch Today - October 5th MarketBeat report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE TradingKey • 21h ago
Top U.S. Stock Losers: Biggest Price Declines TradingKey report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🔴 RISK WATCH Cinema Express • 1d ago
Jailer 2: Hrithik Roshan acknowledges cameo in Rajinikanth starrer, drops his character BGM Cinema Express report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🟡 MARKET WIRE kalkine.ca • 1d ago
Qilian International Holding Group Limited (NASDAQ: BGM) Stock Price, News & Analysis kalkine.ca report covering BGM Group Ltd. (Class A) (BGM) market action, institutional positioning, and fundamental catalysts.
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE
3 Active Posts & Replies
BGM Bull vs. Bear Conversation Board — What's Your Call at $9.54?
🐂 33% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON BGM 🐻 67% BEARISH CONVICTION
RO RoarDesk_Moderator Roarable Research Desk 🐻 BEARISH
🎯 Target: $8.40 (-11.9%)
📌 Pinned Debate 🔥 Official Bull vs. Bear Debate: Is BGM (D- • RQD 35/100) a Buy at $9.54?
Welcome to the BGM (BGM Group Ltd. (Class A)) Roar Pit. Current RQD Composite is 35/100 (Roarable Sell — Vulnerable Balance Sheet & Flow) in Biotechnology: Pharmaceutical Preparations. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.
SK SkepticalCFA Forensic Accounting Watch 🐻 BEARISH
🎯 Target: $7.25 (-24.0%)
Spot @ $9.54 Pump the brakes on BGM — check the valuation vs. margin headwinds
Everyone in here is repeating the bull case on BGM, but look at what you are paying: current EV/EBITDA multiples with 16.6% gross margins. Unless BGM Group Ltd. (Class A) expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.
SI SiliconVal_Bull Verified K Arena Trader 🐂 BULLISH
🎯 Target: $12.12 (+27.0%)
Spot @ $9.54 BGM cash flow & RQD setup is being underpriced by the Street here
Looking at the 5-pillar RQD breakdown on BGM, the market is fixating on short-term headline noise in Biotechnology: Pharmaceutical Preparations and ignoring the balance sheet and cash flow trajectory. At $9.54 (52-wk range $8.63 - $10.73), any beat on forward guidance forces shorts and underweight funds to chase.